Exelixis | Lånekapital



Loan Capital Endring Dato
Acadia Pharmaceuticals USD 0 0 2024-12
Agios Pharmaceuticals USD 0 0 2025-03
Amgen USD 54.01B 2.54B 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Bayer EUR 34.55B 2.12B 2024-12
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Cytokinetics USD 645.6M 1.1M 2024-12
Eisai JPY 99.82B 9M 2024-12
Eli Lilly USD 34.5B 5.97B 2025-03
Exelixis USD 0 0 2025-01
Genmab DKK 937M 41M 2024-12
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Incyte USD 32.64M 899K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
MacroGenics USD 0 0 2024-12
Merck USD 34.46B 520M 2024-12
Moderna USD 35M 4M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.4B 597M 2024-12
Sanofi 11.79B 712M 2024-12
Takeda JPY 4.7T 277.59B 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Xencor USD 115.16M 104.99M 2024-12



Exelixis Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.